scholarly journals An obstructive tongue neurofibroma

Author(s):  
Gama R ◽  
◽  
Sousa M ◽  
Castro F ◽  
Condé A ◽  
...  

Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder characterized by multiple manifestations, including the presence of neurofibromas. These benign lesions can potentially affect every site of the body; its location in the head and neck region is not uncommon, but the oral cavity, and specially the tongue, are rarely affected. We aim to present a case of a giant recurrent neurofibroma of the tongue in a NF1 patient, conditiong obstructive symptoms, as well as to ouline its successful treatment with topical mitomycin-C as an adjuvant therapy to surgical ressection. Keywords: neurofibromatosis; neurofibroma; recurrence; airway obstruction.

2020 ◽  
Vol 13 (1) ◽  
pp. e227379
Author(s):  
Gustavo Ferrer ◽  
Alwiya Omar Saleh ◽  
Henry D Tazelaar ◽  
Andrea V Arrossi

Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder with multiple systemic manifestations. Pulmonary involvement has been reported in the form of interstitial fibrosis, emphysema, pulmonary hypertension and thoracic neoplasm. We report a case of desquamative interstitial pneumonia in a non-smoker with NF1.


2021 ◽  
Vol 6 (4) ◽  
pp. 288-290
Author(s):  
Punam Prasad Bhadani ◽  
Sneha Aditi ◽  
Avinash Singh

Epidermal inclusion cysts (EIC) are benign lesions that can be encountered throughout the body, but with a low incidence in the head and neck region. (1.6 to 7%) The various locations in this region where the cyst can arise are sublingual, submental, submandibular and buccal mucosa. EIC present in the tonsils are extremely rare and reported less than 0.01% in published English literature. We report a rare and incidental finding of epidermal inclusion cyst with actinomycetes in tonsil in a 57 year old male who presented with sore throat and difficulty in swallowing.


2000 ◽  
Vol 114 (2) ◽  
pp. 119-124 ◽  
Author(s):  
M. P. Colreavy ◽  
P. D. Lacy ◽  
J. Hughes ◽  
D. Bouchier-Hayes ◽  
P. Brennan ◽  
...  

Schwannomas of the head and neck are uncommon tumours that arise from any peripheral, cranial or autonomic nerve. Twenty-five to 45 per cent of extracranial schwannomas occur in the head and neck region and thus are usually in the domain of the otolaryngologist. They usually present insidiously and thus are often diagnosed incorrectly or after lengthy delays, however, better imaging and cytological techniques have lessened this to some degree more recently. For benign lesions conservative surgical excision is the treatment of choice bearing in mind possible vagal or sympathetic chain injury. Malignant schwannomas are best treated with wide excision where possible. The role of adjuvant therapy remains uncertain and irrespective of treatment modality prognosis is poor with an overall survival of 15 per cent. However, recent advances in ras oncogene inhibitors may hold hope for the future.


2020 ◽  
Vol 7 (50) ◽  
pp. 3067-3069
Author(s):  
Vasu Reddy Challa ◽  
Ajay Chanakya Vallabhaneni ◽  
Baleswari G ◽  
Vinusha Reddy Basi Reddy

Schwannomas are rare benign tumours arising from neuroectodermal Schwann cells. They can arise from cranial, intraspinal, peripheral and autonomic nerve sheaths. Schwannomas represent 1 - 8 % of head and neck tumours. They constitute 25 – 40 % of extracranial tumours in head and neck region.1 Among the schwannomas arising in head and neck region those arising intraorbitally are very rare. The most common benign intra orbital tumours are haemangiomas. They can arise as localised forms or in association with Neurofibromatosis-1 (NF1). In patients with neurofibromatosis-type 1 or in patients with family history of NF, the risk of developing orbital schwannoma is 1.5 %. Schwannomas constitute 1 - 6.5 % of intra orbital tumours.2-6 Of these tumours those undergoing cystic changes are still rare. The most common cystic lesions in the orbit are dermoid cysts or mucoceles.


2012 ◽  
Vol 2012 ◽  
pp. 1-3 ◽  
Author(s):  
Tine Gregersen ◽  
Nanna Holt ◽  
Henning Gronbaek ◽  
Ida Vogel ◽  
Lars J. Jørgensen ◽  
...  

Neuroendocrine tumors are rare tumors primarily located in the gastrointestinal tract. Goblet cell carcinoid is a rare subgroup of neuroendocrine tumors located in the appendix. Neurofibromatosis type 1 is an autosomal dominant disorder caused by a mutation in theNF1gene. Patients with neurofibromatosis type 1 have an increased incidence of typical neuroendocrine tumors, but it is unknown if this is the case with goblet cell carcinoids. We describe a patient with both neurofibromatosis type 1 and goblet cell carcinoid, that according to literature would occur in 0.00017 per million per year. This may suggest a previously unknown association between neurofibromatosis type 1 and goblet cell carcinoids.


2020 ◽  
Vol 6 ◽  
pp. 2513826X2096470
Author(s):  
Kim Phan ◽  
Muralie Vignarajah ◽  
Nasimul Huq

Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder characterized by the formation of benign nerve sheath tumours known as neurofibromas. A 28-year-old female presented with a large neurofibroma extending from the elbow of the right arm into the axilla and across the right breast. A mastectomy was performed to excise 4 kg of tissue with an immediate flap reconstruction. Post-operatively, the patient’s hemoglobin levels dropped significantly due to excessive blood loss, but the patient was discharged by post-operative day 5 with no additional complications. This study raises awareness for NF1, describes possible complications that may arise following excision of highly vascularized neurofibromas, and outlines possible techniques for breast reconstruction.


2021 ◽  
Vol 10 (33) ◽  
pp. 2851-2853
Author(s):  
Deepali Prakash Mohite ◽  
Prakash M. Mohite ◽  
Snehal U. Udapure

Connective tissue neoplasms or soft tissue tumours as they are popularly called are mesenchymal neoplasms that affect any part of the body. They occur frequently in all organs including the head and neck region and the oral cavity is no exception. The frequency of their occurrence contributes to 15 - 20 % of all head and neck neoplasms and neoplasms of oral cavity form 1 - 4 % of the reported lesions,1,2 representing 2.2 % of all lipomas.3 In a study by Moreno SE et al. in 2016 the most frequently affected sites were the buccal mucosa followed by the lips, tongue, palate, and other areas of the oral cavity.4Here we are documenting a case occurring in the buccal mucosa.


2021 ◽  
pp. 13-15
Author(s):  
Surya Rao Rao Venkata Mahipathy ◽  
Alagar Raja Durairaj ◽  
Narayanamurthy Sundaramurthy ◽  
Anand Prasath Jayachandiran ◽  
Suresh Rajendran

Neurobroma is a common benign tumour occurring as part of an autosomal dominant disorder, neurobromatosis type 1, leading to the formation of benign tumours or neurobromas of the peripheral nervous system. Large neurobromas of the brachial plexus are rare and present a difcult challenge for surgeon due to the anatomical complexity of the brachial plexus. Dermal neurobromas usually present with swelling and occasional pain, but neurobromas associated with the brachial plexus present with pain and neurological symptoms. These plexiform neurobromas of the brachial plexus are known to undergo malignant transformation. Here, we present a case of a large plexiform neurobroma affecting the left brachial plexus and extending till the elbow, conrmed with MRI and surgical debulking was done.


Author(s):  
Shalini Jain ◽  
Sahil Maingi ◽  
Ancy S. Sofia ◽  
A. K. Rai

<p class="abstract">Lipoma is a benign mesenchymal tumor with a thirteen percent incidence in head and neck region. Posterior triangle is the most common location while anterior neck lipoma is a rare one. Giant lipomas &gt;10 cm have been reported in different parts of the body but rarely in the anterior neck. Surgical excision remains the treatment of choice. We here report a case of giant anterior neck lipoma in a 50 year old male managed surgically.</p>


2019 ◽  
Vol 6 (1) ◽  
pp. 19
Author(s):  
Yayun Siti Rochmah

Background: Osteoradionecrosis (ORN) post dental extraction is post dentalextraction complication with post radiation cancer theraphy. Objective : to present rare case, ORN post dental extraction with post radiation Ca nasopharing therapy 3 years ago.Case Management: A 54 years old patient reported to the dental out-patient department with a chief complaint of pus discharge from right buccal since post dental extraction 6 months ago. He gave a history of a nasopharing Carcinoma with histopatology as squamous cell carcinoms 3 years ago and radio therapy but no surgery. Intraoral examination, exposed necrotic bone found from right lower retromolar area 46 with pus discharge. Radiographic view was likely squester. Local surgical debridement and the sequestrectomy was undertaken with general anaesthesia. Antibiotic injection treatment was ceftriaxon 2x 1gram, infus metronidazol 3x500 mg and ketorolac 3x1 ampul, the patient was treated for 3 days and educated to maintain his oral hygiene with povidone iodine gargle.Discussion: Osteoradionecrosis (ORN) is late effect of radiation therapy thatresults in irreversible tissue death, which is clinically observed as bony exposure for more than 3 months duration. The mandible is affected more often than the maxilla or any other bones of head and neck region. The incidence of ORN in the mandible is reported to be between 2% and 22% and most often affects the body of the mandible. Ideal time is one year minimal post radiotherapy to get maximal vascularization for optimal healing. But immunity factor and radiation doses can trigger emergense ORN.Conclusion: Need time consideration, clinic analysis and pathologys before doing dental extraction for post radiotherapy cancer cases to prevent ORN.


Sign in / Sign up

Export Citation Format

Share Document